Nautilus Biotechnolgy (NAUT) Stock: Buy, Sell, or Hold?
NAUT - Nautilus Biotechnolgy, Inc. Common Stock
$2.71
0.16 (6.27%)
▲
5d:
+25.46%
30d:
+171.16%
90d:
+53.11%
WAIT
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Oct 27, 2026
4d
Get Alerted When NAUT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: NAUT is 22.6% above its trading range ($2.21). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: NAUT is 22.6% above its trading range ($2.21). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: NAUT is currently trading at $2.71, which is considered extended relative to its 30-day fair value range of $1.02 to $2.21.
Technical Outlook: Technically, NAUT is in a downtrend. Immediate support is located at $1.75, while resistance sits at $2.83. The stock is showing strong short-term momentum, up 6.3% recently.
Market Sentiment: NAUT scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.83 (+41.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NAUT is in a downtrend. Immediate support is located at $1.75, while resistance sits at $2.83. The stock is showing strong short-term momentum, up 6.3% recently.
Market Sentiment: NAUT scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.83 (+41.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.02 -
$2.21
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
Protect Your Profits
NAUT is technically overbought (RSI 74). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+22.6% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.3%)
- BULLISH: Trading 41.5% below Wall St target ($3.83)
- WARNING: Composite score 35/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.02 -
$2.21
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.75
Resistance Level
$2.83
Current Trend
Downtrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.19
Wall Street Target
$3.83
(+41.5%)
Share & Embed Analysis
Last updated: October 22, 2026 7:41 AM ET
Data refreshes hourly during market hours. Next update: 8:41 AM
Data refreshes hourly during market hours. Next update: 8:41 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NAUT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 71 BUY |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 69 BUY |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
20 analysts |
$17 | 58 HOLD |
|
ARWR
Arrowhead Pharmaceutical… |
STRONG BUY
15 analysts |
$108 | 68 BUY |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
14 analysts |
$153 | 63 BUY |
Advanced NAUT Option Strategies
Professional options setups generated by AI based on today's NAUT price and gamma walls.
